|
Originally published In Press as doi:10.1074/jbc.M001757200 on May 25, 2000
J. Biol. Chem., Vol. 275, Issue 33, 25831-25839, August 18, 2000
Non-erythroid Genes Inserted on Either Side of Human HS-40 Impair
the Activation of Its Natural -Globin Gene Targets without Being
Themselves Preferentially Activated*
Corinne
Espéret §,
Sandrine
Sabatier §,
Marie-Alice
Deville ,
Roland
Ouazana ,
Eric E.
Bouhassira¶,
Jacqueline
Godet ,
François
Morlé , and
Agnès
Bernet
From the Centre de Génétique
Moléculaire et Cellulaire, CNRS UMR 5534, 69622 Villeurbanne,
France and the ¶ Albert Einstein College of Medicine,
Bronx, New York 10461
The human -globin gene complex includes three
functional globin genes (5'- 2- 2- 1-3') regulated by a common
positive regulatory element named HS-40 displaying strong
erythroid-specific enhancer activity. How this enhancer activity can be
shared between different promoters present at different positions in
the same complex is poorly understood. To address this question, we
used homologous recombination to target the insertion of marker genes
driven by cytomegalovirus or long terminal repeat promoters in both
possible orientations either upstream or downstream from the HS-40
region into the single human -globin gene locus present in hybrid
mouse erythroleukemia cells. We also used CRE
recombinase-mediated cassette exchange to target the insertion of a
tagged -globin gene at the same position downstream from HS-40. All
these insertions led to a similar decrease in the
HS-40-dependent transcription of downstream human
-globin genes in differentiated cells. Interestingly, this decrease
is associated with the strong activation of the proximal newly inserted
-globin gene, whereas in marked contrast, the transcription of the
non-erythroid marker genes remains insensitive to HS-40. Taken
together, these results indicate that the enhancer activity of HS-40
can be trapped by non-erythroid promoters in both upstream and
downstream directions without necessarily leading to their own activation.
*
This work was supported by Association pour la Recherche
contre le Cancer Grants 1508 and 9764 and by grants from the Ligue Nationale contre le Cancer, CNRS, and University Lyon I.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
To whom correspondence should be addressed: Centre de
Génétique Moléculaire et Cellulaire, CNRS UMR 5534, Bât. 741, 43 Boulevard du 11 Novembre 1918, 69622 Villeurbanne,
France. Tel.: 33-04-72-44-62-89; Fax: 33-04-72-44-05-55; E-mail:
bernet@biomserv.univ-lyon1.fr.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. De Gobbi, V. Viprakasit, J. R. Hughes, C. Fisher, V. J. Buckle, H. Ayyub, R. J. Gibbons, D. Vernimmen, Y. Yoshinaga, P. de Jong, et al.
A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter.
Science,
May 26, 2006;
312(5777):
1215 - 1217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-A. Deville, R. Ouazana, F. Morle, and A. Bernet
Disruption of the Mechanism of Long Range Activation within the Human {alpha}-Globin Complex
J. Biol. Chem.,
May 21, 2004;
279(21):
21793 - 21801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Anguita, J. A. Sharpe, J. A. Sloane-Stanley, C. Tufarelli, D. R. Higgs, and W. G. Wood
Deletion of the mouse alpha -globin regulatory element (HS -26) has an unexpectedly mild phenotype
Blood,
November 15, 2002;
100(10):
3450 - 3456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Eszterhas, E. E. Bouhassira, D. I. K. Martin, and S. Fiering
Transcriptional Interference by Independently Regulated Genes Occurs in Any Relative Arrangement of the Genes and Is Influenced by Chromosomal Integration Position
Mol. Cell. Biol.,
January 15, 2002;
22(2):
469 - 479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Bender, J. N. Roach, J. Halow, J. Close, R. Alami, E. E. Bouhassira, M. Groudine, and S. N. Fiering
Targeted deletion of 5'HS1 and 5'HS4 of the {beta}-globin locus control region reveals additive activity of the DNaseI hypersensitive sites
Blood,
October 1, 2001;
98(7):
2022 - 2027.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|